INTRODUCTION
============

Freezing of gait (FOG) is one of the most disturbing and least poorly understood gait phenomenon in people with Parkinson disease (PD) ([@b18-jer-15-2-187]). In the early PD stage, about 20% of patients report FOG, but the prevalence of this phenomenon raises up to 50% in the advanced disease stages ([@b10-jer-15-2-187]). People with PD (PwPD) are experience FOG in various situations: when starting to walk, during turning, when approaching a narrow space, and just before reaching destination ([@b8-jer-15-2-187]). FOG is highly impairs mobility, causes falls, limits activities of daily living and reduces quality of life ([@b4-jer-15-2-187]; [@b6-jer-15-2-187]; [@b12-jer-15-2-187]). Since the pathogenesis of FOG is still unclear, no available treatment for this disabling phenomenon ([@b18-jer-15-2-187]). The pharmacological treatment is disappointing: PwPD and FOG in "off" states gained more benefit from an increase in levodopa dosage, this was not observed in the same patient in "on" states ([@b23-jer-15-2-187]). In addition, the surgical treatment (deep brain stimulation) and levodopa, are insufficient for treating FOG ([@b7-jer-15-2-187]).

The nonpharmacological interventions like rehabilitation are a possible treatment for gait disorders in PwPD. Several physical therapy (PT) approaches have been employed in PD rehabilitation protocols for helping patients overcome PD symptoms and FOG episodes ([@b1-jer-15-2-187]; [@b5-jer-15-2-187]; [@b8-jer-15-2-187]; [@b13-jer-15-2-187]; [@b19-jer-15-2-187]). These approaches include transcranial direct current stimulation, auditory and visual cueing training and virtual reality training ([@b5-jer-15-2-187]; [@b8-jer-15-2-187]; [@b13-jer-15-2-187]). Many studies have shown the efficacy of PT interventions at improving specific impairments and functional limitations in PwPD ([@b2-jer-15-2-187]; [@b11-jer-15-2-187]; [@b16-jer-15-2-187]). In particular, they have shown that PT interventions can reduce the incidence and duration of FOG episodes ([@b5-jer-15-2-187]; [@b8-jer-15-2-187]; [@b13-jer-15-2-187]; [@b19-jer-15-2-187]). However, to date, findings are not univocal, and long-term consolidation of performance improvement needs to be investigated in future studies.

There is growing interest in using robot-assisted gait training (RAGT) as a new PT technology for meeting the therapeutic gaps associated with PD and FOG. In our recent systematic review and meta-analysis, RAGT showed better outcomes than conventional interventions on some motor aspects in PD ([@b2-jer-15-2-187]). In line with our results, previous studies in PD and other neurological disease such as stroke and spinal cord injury that used RAGT showed significant improvements in gait and balance, compared with conventional rehabilitation programs ([@b9-jer-15-2-187]; [@b20-jer-15-2-187]; [@b22-jer-15-2-187]). However, to our knowledge, no systematic review and/or review of the literature investigates the effect of RAGT on PwPD and FOG. Therefore, the objectives of this review are to evaluate, summarise and discuss the available literature concerning the effect of RAGT on FOG.

MATERIALS AND METHODS
=====================

A comprehensive literature search was conducted utilizing of MEDLINE, Embase, Scopus, Web of Science, PEDro (Physiotherapy Evidence Database), and the Cochrane Review. The search included studies published from January 1990 to October 2018. Search terms used included 'Parkinson disease,' 'Freezing of gait,' 'RAGT,' 'robot-assisted gait training,' 'Locomotor rehabilitation training,' 'gait trainer,' and 'robotics assisted gait training.' Search strategies were developed for each database using both free-text terms and the MeSH (medical subject headings). The reference lists of relevant articles were screened for potential related articles.

Inclusion was dependent on the following criteria: participants: PwPD diagnosed according to the Criteria of UK Parkinson's Disease Brain Bank or confirmed by medical diagnosis, and presence with FOG. Any study investigated the effects of RAGT on FOG. The primary outcomes are Freezing of Gait-Questionnaire (FOG-Q) and Unified Parkinson Disease Rating Scale Part III (UPDRS III). Secondary outcomes include balance, gait, and posture measurements. Studies including participants with neurological conditions other than PD were excluded. Studies in language other than English, systematic reviews and meta-analyses were not included in the current review. Data related to study design, duration and frequency of the RAGT intervention program, sample size, and outcome measures were extracted for qualitative analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA).

RESULTS
=======

Of the 1948 papers reviewed, four studies ([@b3-jer-15-2-187]; [@b14-jer-15-2-187]; [@b21-jer-15-2-187]; [@b25-jer-15-2-187]) were relevant to the specified criteria, detailing the use of RAGT to treat FOG in PwPD. Retrieved data are presented in [Table 1](#t1-jer-15-2-187){ref-type="table"}, their year of publication spanning from 2010 to 2015. Studies varied in size and outcome measures, and most had poor methodological quality. The total number of participants was 26, and age range was 63--67 years and the range of PD duration was 6.18--11.5 years. PD severity according to H&Y staging scale ranged from 2.5 to 3.5 in all studies, except one study ([@b14-jer-15-2-187]), the authors did not report the H&Y stage. Mini Mental Status Examination used in 2 of the included studies ([@b3-jer-15-2-187]; [@b21-jer-15-2-187]) to eliminate potential cognitive impairment. All the included studies reported that the participant trained and were tested during their usual medication ('ON' medication phase). Two studies assessed the long term effect of RAGT, [@b3-jer-15-2-187] assessed after 6 weeks, and [@b25-jer-15-2-187] assessed the effect after 15 weeks. All studies used RAGT as an experimental intervention supervised by a physiotherapist. The RAGT devices used in the included studies were Lokomat ([@b3-jer-15-2-187]; [@b14-jer-15-2-187]; [@b25-jer-15-2-187]), except [@b21-jer-15-2-187] did not report the RAGT device. RAGT was performed at speed ranged from 0.7 to 2.5 km/hr in all the included studies. The frequency of the treatment ranged from one to three times per week during 'on' medication phase in all included studies. The treatment duration (in terms of session duration) ranged from 30 to 40 min. The summary of the interventions is presented in [Table 1](#t1-jer-15-2-187){ref-type="table"}. Most of the studies were of low-level evidence including three case studies ([@b3-jer-15-2-187]; [@b14-jer-15-2-187]; [@b25-jer-15-2-187]) and one uncontrolled experimental study ([@b21-jer-15-2-187]).

Effect of RAGT on FOG
---------------------

All the included studies in this review concluded positive outcomes with using RAGT to treat FOG. [@b14-jer-15-2-187] examined the potential effect of continuous physical cueing using robot-assisted sensorimotor gait training on reducing FOG episodes and improving gait. Four subjects participated in this pilot study, the median age was 63.25 years, disease duration was 6.18 years and median UPDRS III score was 20.5. Participants trained twice a week for five weeks in an "on" phase medication, and each training session on the RAGT (Lokomat, Hocoma, Zurich, Switzerland) for 30 min. All participants started RAGT speed with 1 km/hr, and 40% body weight-support. Speed was increased to a range of 2.2 to 2.5 km/hr before body weight-support was decreased. The authors used different outcomes measures to assess the participant at baseline and after RAGT intervention. The primary outcome measurements utilized in this study included the FOG-Q, FOG, and Falls Diary and Visual FOG (vFOG). The authors reported that 20.7% reduction in average frequency of freezes per day as recorded on the FOG calendars, with three participants reporting 2--3 fewer episodes of freezing per day. In addition, they observed that 13.8% improvement on the FOG-Q from baseline to end of training and severity of freezing improved 41.7% in "overall" and "initiation" FOG, which correspond to questions 4 and 5 of the FOG-Q. Moreover, median frequency vFOG scores improved 73.2% immediately following training sessions. Additionally, median frequency vFOG scores improved 62.5% from baseline to end of training. The severity of FOG was reduced in all walking contexts for all participants from baseline to end of training. The authors reported that there were no serious adverse events related to the study ([@b14-jer-15-2-187]). [@b3-jer-15-2-187] set up a pilot study to evaluate the long-term effects of RAGT on FOG reduction. Three subjects participated in this study, the median age was 64.0 years and median UPDRS III score was 31. All participants received 10--12 training sessions of 30 min on RAGT (Lokomat, Hocoma, Switzerland) in an "on" phase medication. The gait speed started at 1.5 km/hr, fully assisted leg movements and a body weight support of 70%. In the training session, body weight support was initially set at 100% and was then gradually reduced to 70%. The FOG assessed by FOG-Q, it's completed before and after the intervention, and also after a 6-week follow-up for evaluation of long-term effects. The authors reported that RAGT improved significantly post interventions (FOG-Q, 15.3 to 10.3) but no significant effect was observed after 6 weeks of RAGT interventions ([@b3-jer-15-2-187]).

[@b25-jer-15-2-187] utilized a study to assess the effect of RAGT in one patient with moderate PD. In this case study, a 67-year-old female with more than an 8-year history of PD. The participant performed six sessions for 25--40 min of RAGT (Lokomat) on their "on" state medication, each week she trained 3 times a week for 2 weeks. The patient started training with walking for 25 min (walking distance, 0.7 km), then gradually increasing by 3- to 4-min increment each session to 42 min (walking distance, 1.2 km). Body weight support was gradually reduced from 44% at the beginning of therapy to 29% by the end. RAGT performed in front of a mirror where the patient could watch her performance, supplementing somatosensory feedback from the lower extremities with additional visual cues. Items 14 in unified Parkinson disease rating scale used to assess the FOG. The authors observed a significant change in walking activities, with a reduced occurrence of freezing episodes post RAGT ([@b25-jer-15-2-187]).

[@b21-jer-15-2-187] evaluated the effectiveness of RAGT on FOG severity and gait abnormalities in PwPD. Eighteen subjects median age 64.5 years with PD and FOG resistant to dopaminergic medications participated in this study. All participants were trained on RAGT (Rehastim, Berlin) for 30 min, in 5 days a week for 3 consecutive weeks. Walking speed was set for each patient at a comfortable velocity (range, 0.5--2 km/hr). Severity of FOG is assessed by FOG-Q at baseline and after the RAGT intervention. The authors found that FOG-Q score was reduced from 13±3.39 at baseline to 9.2±5.44 after treatment (*P*=0.023). In addition, the gait parameters and functional balance were significantly improved after RAGT interventions ([@b21-jer-15-2-187]).

Effect of RAGT on spatiotemporal gait characteristics and balance
-----------------------------------------------------------------

Spatiotemporal gait parameters represented as stride length, stride time, one and double leg support time, and cadence. Gait parameters measured by different ways in three included studies. [@b14-jer-15-2-187] used a 29-foot instrumented walkway to record these gait parameters. They reported significant improvement in gait velocity and stride length 24.1% and 23.8%, respectively after RAGT. In addition, step length, stride length, swing time and stride time significantly reduced after RAGT. [@b3-jer-15-2-187] reported also a significant increase in step length and a decrease in step length variation. Moreover, the number of steps and walking time for 6 m were reduced significantly after RAGT. [@b25-jer-15-2-187] reported a significant improvement for gait velocity in their case study after RAGT. They observed that the gait cadence increased 66%, turning time decreased 56%, and stride length increased 27% after RAGT.

Balance also showed significant improvement in favour of RAGT. Two studies used the UPDRS items 13--15 and 29--30 to assess gait and balance ([@b14-jer-15-2-187]; [@b25-jer-15-2-187]). Both studies reported a reduction in the UPSDRS items after RAGT, which means gait and balance improved after RAGT. Moreover, [@b21-jer-15-2-187] used Bearg balance scale, time up and go test and Fear of Falling Efficacy Scale to evaluate clinical measures of balance, the risk of falling, and functional mobility. They reported a significant improvement in functional balance after RAGT. These improvements of self-perceived steadiness and objective balance performances indicating a positive effect of RAGT intervention.

DISCUSSION
==========

Our aim with this review was to evaluate the currently available published data on the use of RAGT to treat FOG in PwPD. All the 4 studies and reports reviewed noted positive outcomes with using RAGT on FOG, gait parameters and balance. All studies reported that were no adverse events or side effects that occurred during and/or after the interventions. Numerous studies also emphasized improved motor impairments, gait and balance in participants when using RAGT ([@b2-jer-15-2-187]; [@b9-jer-15-2-187]; [@b20-jer-15-2-187]; [@b22-jer-15-2-187]).

The amelioration in FOG, gait and balance could explain by different hypothesis. The several repetitions of rhythmic limb movements could act as an external proprioceptive cue, by reinforcing the neuronal circuits that contribute to the lower limb movements ([@b17-jer-15-2-187]). Additionally, proprioceptive cues have been proposed to share the same mechanism of visual and auditory cues, so it is plausible that they might be involved in the gait improvements observed in PwPD after RAGT ([@b15-jer-15-2-187]; [@b24-jer-15-2-187]). In line with this suggestion, we argue that RAGT could improve FOG and gait function in PwPD. The use of RAGT may improve compliance due to its ability to make therapy sessions more enjoyable. The increasing availability, low cost, and safety of RAGT systems further reinforces the use of RAGT in the setting of PD rehabilitation ([@b2-jer-15-2-187]).

However, despite the predominately beneficial effects of RAGT noted, the quality of evidence of current literature remains low. The studies were predominantly case reports and the remaining varied in size and outcome measures; therefore, it was not possible to compare and pool data for formal meta-analysis. Moreover, the included studies in this review performed the assessments and training during usual medication ('ON' medication). Assessment of motor impairments without medication ('OFF' medication) is important because the patients experienced more difficulties in motor function than on-medication whereas the symptoms are satisfactory controlled with medication. Nevertheless, despite these limitations, the reported studies show some encouraging findings that would deserve to be investigated by means of larger randomized controlled trials with standardized treatment protocols.

In conclusion, overall, while generally supportive, only very limited evidence is available to support the use of RAGT to treat FOG in PwPD. As a rehabilitation modality, RAGT has the potential and feasibility to provide significant therapy options for PwPD and FOG, yet remains to be fully investigated at this time ([Fig. 1](#f1-jer-15-2-187){ref-type="fig"}).
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###### 

The summary and characteristics of the included studies

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                 Study type                  Participants, demographical, and clinical data                               Outcome measurements           Device type   Duration of intervention   Total No. of sessions   Main results
  --------------------- --------------------------- ---------------------------------------------------------------------------- ------------------------------ ------------- -------------------------- ----------------------- ------------------------------------------------------------------------------------------------------------------------
  [@b14-jer-15-2-187]   Case study                  n=4; Age: 63.25±17.29 yr; PD duration: 6.18±5.91 yr; UPDRS-III: 20.75±9.07   FOG-Q, FOG falls diary, vFOG   Lokomat       30 min× 2/wk×5 wk          10                      Significant improvement in frequency of freezes per day\
                                                                                                                                                                                                                                 FOG-Q scores and FOG severity significantly improved after RAGT.

  [@b3-jer-15-2-187]    Case study                  n=3; Age: 64±4.36 yr; Pd duration: 7.67±2.08; UPDRS-III: 31±13.89            FOG-Q                          Lokomat       30 min                     10--12                  FOG significantly improved after RAGT intervention.\
                                                                                                                                                                                                                                 No significant improvement observed after 6 weeks of RAGT interventions.

  [@b25-jer-15-2-187]   Case study                  n=1; Age: 67 yr; PD duration: 8; UPDRS-III: 40                               UPDRS item 14                  Lokomat       25--40 min× 3/wk×2 wk      6                       Walking activities significantly improved and the occurrence of freezing episodes is reduced after RAGT interventions.

  [@b21-jer-15-2-187]   Pilot, uncontrolled study   n=18; Age: 64.5 yr; PD duration: 11.5; UPDRS-III: 24.235                     FOG-Q                          NR            30 min× 5/wk×3 wk          15                      FOG, gait parameters and functional balance improved significantly after RAGT interventions.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FOG, freezing of gait; FOG-Q, freezing of gait questionnaire; vFOG, visual freezing of gait; NR, not reported; PD, Parkinson disease; RAGT, robot-assisted gait training; UPDRS-III, Unified Parkinson's Disease Rating scale-motor part III.
